AN SH3 DOMAIN IS REQUIRED FOR THE MITOGENIC ACTIVITY OF MICROINJECTED PHOSPHOLIPASE C-GAMMA-1

被引:60
作者
HUANG, PS
DAVIS, L
HUBER, H
GOODHART, PJ
WEGRZYN, RE
OLIFF, A
HEIMBROOK, DC
机构
[1] Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486
关键词
PHOSPHOLIPASE C; SH2; SH3; MITOGENIC STIMULATION; MICROINJECTION;
D O I
10.1016/0014-5793(94)01453-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phospholipase activity is elevated in dividing cells. In response to growth factor stimulation, phospholipase C-gamma (PLC-gamma) binds to activated tyrosine kinase receptors via SH2 binding domains, resulting in phosphorylation of PLC-gamma and activation of its enzyme activity. These observations suggest that PLC-gamma participates in the signal transduction pathway employed by growth factors to promote mitogenesis. Consistent with this hypothesis, microinjection of purified bovine PLC-gamma into quiescent fibroblasts has been previously reported to initiate a mitogenic response [Smith et al. (1989) Proc. Natl. Acad. Sci. 86, 3659]. We have reproduced this result using recombinant rat PLC-gamma protein. Surprisingly however, a catalytically inactive mutant of PLC-gamma, H335Q, also elicited a full mitogenic response. The capacity to induce mitogenesis by microinjection of PLC-gamma was mapped to the 'Z' domain of the protein, which contains PLC-gamma's SH2 and SH3 motifs. Inactivation of the phosphorylated tyrosine binding properties of both SH2 domains had no effect on the mitogenic activity of the Z-domain peptide. However, deletion of the SH3 domain resulted in a complete loss of activity. These results suggest that PLC-gamma's mitogenic properties do not require the enzyme's phospholipase activity, but are instead mediated by a novel pathway for mitogenic stimulation which is dependent upon an intact SH3 domain.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 40 条
[1]   PHOSPHATIDYLINOSITOL-DERIVED PRECURSORS AND SIGNALS [J].
BANSAL, VS ;
MAJERUS, PW .
ANNUAL REVIEW OF CELL BIOLOGY, 1990, 6 :41-67
[2]   SH3 DOMAINS DIRECT CELLULAR-LOCALIZATION OF SIGNALING MOLECULES [J].
BARSAGI, D ;
ROTIN, D ;
BATZER, A ;
MANDIYAN, V ;
SCHLESSINGER, J .
CELL, 1993, 74 (01) :83-91
[3]  
BARSAGI D, 1987, SCIENCE, V233, P1061
[4]  
CHICCHETTI P, 1992, SCIENCE, V257, P803
[5]   THE SH2-CONTAINING AND SH3-CONTAINING NCK PROTEIN TRANSFORMS MAMMALIAN FIBROBLASTS IN THE ABSENCE OF ELEVATED PHOSPHOTYROSINE LEVELS [J].
CHOU, MM ;
FAJARDO, JE ;
HANAFUSA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (12) :5834-5842
[6]  
CUADRADO A, 1993, ONCOGENE, V8, P2443
[7]  
DEVIVO M, 1992, J BIOL CHEM, V267, P18263
[8]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346
[9]   CLONING OF A GRB2 ISOFORM WITH APOPTOTIC PROPERTIES [J].
FATH, I ;
SCHWEIGHOFFER, F ;
REY, I ;
MULTON, MC ;
BOIZIAU, J ;
DUCHESNE, M ;
TOCQUE, B .
SCIENCE, 1994, 264 (5161) :971-974
[10]   DELETION OF AN N-TERMINAL REGULATORY DOMAIN OF THE C-ABL TYROSINE KINASE ACTIVATES ITS ONCOGENIC POTENTIAL [J].
FRANZ, WM ;
BERGER, P ;
WANG, JYJ .
EMBO JOURNAL, 1989, 8 (01) :137-147